Curaleaf Stock Price Target

Historical volatility can be compared with implied volatility to determine if a stock's options are over- or undervalued. 02 (This CURALEAF HOLDINGS INC probability density function shows the probability of CURALEAF HOLDINGS OTC Stock to fall within a particular range of prices over 30 days). 70 Nobody can reliably foresee how stock prices may evolve in the future. Curaleaf Stock Performance. With respect to the terms of each of the Original Merger Agreement and the Amended Merger Agreement, Curaleaf has relied upon the exemptions provided under Sections 5. Curaleaf Arizona provides Arizona patients pharmaceutical-grade, standardized-dose medical cannabis to improve health and well-being. Curaleaf’s stock suffered more, selling off 7% and continuing its decline yesterday. The North American Marijuana Index, which tracks the top cannabis stocks. Free forex prices, toplists, indices and lots more. The analyst reiterates a Buy rating on Curaleaf stock, with a price target of $11. Latest price update. Buoyed by strong sequential growth, re-iterated guidance and a CVS Health few saw coming, the stock appears poised to continue rallying tomorrow. Securities products and services offered to self-directed investors through ST Invest, LLC. analyst estimates by MarketWatch. The volatility of a stock over a given time period. Saturday, October 19, 2019. of Brokers 8 Median Target 19. Cannabis stocks led higher by Curaleaf after company buys Chicago-based multistate operator He reiterated his buy rating on the stock and price target of $10 that is three times its current. According to the company's press release, Curaleaf will provide medical cannabis patients. 1% in the. The stock, which began trading Oct. Seaport analyst Brett Hundley went so far as to say that the letter was a "non-event" for the company and that now the stock is a good buying opportunity after falling on Tuesday. Say what you will about the reliability of Wall Street analysts, but that is a significant upside. 5 million in 2019, and his ambitious C$20. legalize marijuana. The deal resulted in a sorely needed boost — one that that has. The deal will offer both the companies the ability to diversify and leverage upon an already existing retail channel and brand. of Brokers 8 Median Target 19. Curaleaf reported 2018 Q3 revenue of $21. Analyst Matt Bottomley from Canaccord Genuity rated Curaleaf Holdings Inc (CURA – Research Report) a Buy, setting a C$13 price target. Along with the recent acquisitions of Select and Grassroots Cannabis, Curaleaf’s management expects its pro forma revenues to exceed $1. (To watch Hundley's track record, click here ) Hundley commented, "We view any weakness in CURLF shares as near-term buying opportunities for investors. state to legalize recreational cannabis last month. We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. On the first day of 2018, widely followed analyst Gene Munster of the venture capital firm Loup Ventures predicted Amazon would buy Target this year, a forecast that has yet to pan out with 22. The US vertically integrated cannabis company Curaleaf Holdings Inc announced Monday that effective immediately it would begin trading on the Canadian Securities Exchange as CURA after raising CA$520M in a private placement offering. Aurora's outsized exposure to medical cannabis relative to peers is another challenge to growth as most medical markets are showing flat to declining. The stock price saw a low of $9. 00, which implies nearly 50% upside from current levels. Securities products and services offered to self-directed investors through ST Invest, LLC. 99 and a low estimate of C$5. Prior to the deal, Stanley held a $23 price target but. 000 CAD Lowest Target Stock quotes by finanzen. 5 million in 2019, and his ambitious C$20. Wall Street’s Top Cannabis Analyst Issues Price Targets and Initiates Coverage on 5 U. Curaleaf Holdings (CSE: CURA) (OTCQX: CURLF) reported a purchase of 100,000 shares of its stock by Executive Chairman Boris Jordan. 54, or over 7%, to close at $7. 50 price target and Cresco Labs (CRLBF) with a $14 price target. Buoyed by strong sequential growth, re-iterated guidance and a CVS Health few saw coming, the stock appears poised to continue rallying tomorrow. "We believe that the. Get instant access to a free live streaming chart of the Curaleaf Holdings Inc Stock. We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. analyst Vivien Azer initiated coverage of MedMen Enterprises on Friday with an Underperform rating and a price target of US$1. CURLF The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of EGBN, MNK and CURLF. 50 target, and Cresco Labs Inc. This press release is not an offer of securities for sale in the United States, and the securities described in this press release may not be offered or sold in the United States absent registration or an exemption from. "We believe that the. Find real-time CURLF - Curaleaf Holdings Inc stock quotes, company profile, news and forecasts from CNN Business. 000 CAD Lowest Target Stock quotes by finanzen. Following the company’s announcement, Canaccord Genuity raised the target price Curaleaf stock to 16 Canadian dollars from 14 Canadian dollars. Acres has developed a range of cannabis operations in the state of Nevada. Curaleaf’s stock closed up 18% the day it announced the acquisition. Wall Street Stock Market & Finance report, prediction for the future: You'll find the CURALEAF HLDGS INC (LDVTF) share forecasts, stock quote and buy / sell signals below. Cannabis stocks a sea of red as Green Organic’s financing woes weigh MarketWatch. 00 and the low price target for CURLF is $5. Curaleaf Holdings Stock Price Forecast, CURLF stock price prediction. TSE:CURA's price target is C$16. multiple, which generates our price target of $13. Aurora Cannabis NEW PRICE TARGET, Canntrust, iAnthus, Curaleaf, Organigram. 5(a) of MI 61-101 – Issuer. View Analyst Price Targets for Curaleaf. The brokerage issued a sell rating and a $5. Acreage Holdings ( ACRGF ) was initiated market perform with a $9 price target, indicating 8. While this stock might not have as high a target price as Curaleaf, it certainly has the triple-digit growth in share price. View Analyst Price Targets for Curaleaf. (CURLF) at outperform with a $10. Curaleaf (OTC: CURLF) is a CBD company operating 42 dispensaries and 12 cultivation sites over 12 states. 29 after a reverse takeover on the CSE, hit a high of $11. Canopy Growth Corporation - CGC - Stock Price Today - Zacks CGC is down -4. This is a Real-time headline. 28 million and a net loss of $0. Analyst Matt Bottomley from Canaccord Genuity rated Curaleaf Holdings Inc (CURA - Research Report) a Buy, setting a C$13 price target. The 3-month volatility stands at 74. Alibaba stock closed at 151. This is 190% above Curaleaf's current price of $8. The US vertically integrated cannabis company Curaleaf Holdings Inc announced Monday that effective immediately it would begin trading on the Canadian Securities Exchange as CURA after raising CA$520M in a private placement offering. com, Kirk is ranked #4736 out of 5549 analysts. 06% at outperform with a $10. The North American Marijuana Index, which tracks the. Thursday, October 10. CURA shares are on track to follow Stanley's narrative and are setting up nicely to close the week strong. Bank of America Merrill Lynch gives the note "NEUTRAL" instead of the previous "BUY". com, Bottomley is ranked #555 out of 5100 analysts. 9 billion market capitalization to create. Curaleaf stock price target cut to $9. Hundley commented, “We view any weakness in CURLF shares as near-term buying opportunities for investors. shares of Curaleaf hold an average price target of C$16. 11:53 AM ET. The target price also increases from US $ 46 to US $ 27. Curaleaf (OTC: CURLF) is a CBD company operating 42 dispensaries and 12 cultivation sites over 12 states. Their average twelve-month price target is $8. Following the company's announcement, Canaccord Genuity raised the target price Curaleaf stock to 16 Canadian dollars from 14 Canadian dollars. 09:50 AM ET. Our Curaleaf Holdings Inc (CURA) consensus estimates gives you the next 12-Months price consensus forecasts, based on industry's top analysts. Since the Company generates low operating margins, an appropriate valuation metric would be EV/EBITDA, which Bombardier trades at 30. L) also gained 9%. Curaleaf Hldgs Inc. 30, that puts the total purchase price at C$1. Currently, the company trades at a discount of 42. Grassroots Cannabis is set to be acquired for $875 million, becoming the latest Chicago-based marijuana company to draw a blockbuster price tag from an out-of-state operator. 1% in the. Free forex prices, toplists, indices and lots more. The deal is valued at $30. Jesse Pytlak, I have a C$15 target price on this stock. Azer started Green Thumb Industries Inc. Northland Securities analyst Paul Penney maintained a Buy rating on MedMen Enterprises Inc (MMNFF) today and set a price target of $9. Member FINRA / SIPC. 03 Canadian dollars. Latest price update. Those prospects, together with the anticipated legalization of cannabis in New York and New Jersey, led him to slap a price target of $20 Canadian dollars on the shares, an increase of 133% on. Documents available to potential investors listed the target issue size as $150 million. Wall Street Stock Market & Finance report, prediction for the future: You'll find the Curaleaf Holdings share forecasts, stock quote and buy / sell signals below. 50/200 Simple Moving Average Cross. owned and operated Curaleaf Holdings, Inc. ( See Curaleaf’s price targets and analyst ratings on TipRanks ) Research Report. Curaleaf has the largest cannabis dispensary footprint in the US. With an average price target of $15, analysts clearly think the stock could double in the next 12 months. 70 Nobody can reliably foresee how stock prices may evolve in the future. This press release is not an offer of securities for sale in the United States, and the securities described in this press release may not be offered or sold in the United States absent registration or an exemption from. Curaleaf Holdings (OTCMKTS: CURLF) (CSE: CURA) announced a one day $50M stock buyback to be initiated today, Dec. Price Target Summary for Curaleaf PRICE TARGET No. Highlights Largest retail dispensary chain in the US. Prior to the deal, Stanley held a $23 price target but. Curaleaf is starting to round back up and looks like it can potentially get back over the Ichimoku Cloud. Kirk assigned the stock a C$5 ($3. Curaleaf's report included data that showed retail and wholesale revenue grew at a rate of 500%, totalling $16. MSOs Three of the Leading Multi-State Operators Received Outperform Ratings and Bullish Price Targets One of Wall Street's most respected cannabis analysts initiated coverage on five U. It recovered 18% during the morning but still remained below the issue price at $10. Other gainers Tuesday included Curaleaf Holdings Inc (OTCMKTS:CURLF), which unveiled its 2Q results late last week, reporting revenue of US$48. 75 Canadian dollars. Curaleaf Arizona provides Arizona patients pharmaceutical-grade, standardized-dose medical cannabis to improve health and well-being. The Company is focused on research and development capabilities to distribute cannabis products. Their forecasts range from $5. operator Curaleaf Holdings Inc. com, Bottomley is ranked #555 out of 5100 analysts. analyst estimates by MarketWatch. We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. Companies capitalizing on the booming CBD market is a large part of investor expectations. 49 in early November. Buy rating and a price target of Cdn$13. In addition to maintaining his 'Buy' rating on Curaleaf's stock, Stanley also maintained his price target of $25 CDN, which currently represents an implied ROI of 146% (CURA market price as of this writing). Target stock price target is $107. 50 at Cowen MarketWatch. Stock analysis for Cresco Labs Inc (CRLBF:OTC US) including stock price, stock chart, company news, key statistics, fundamentals and company profile. "This is an exciting time for Curaleaf and our industry, and I have never been more confident in our future. They set a buy rating on the stock. Boris Jordan, Curaleaf executive chairman, joins 'Squawk on the Street' to discuss Curaleaf's acquisition of Cura Partners, the parent of the Select brand, and what it will mean for the industry. Curaleaf’s stock suffered more, selling off 7% and continuing its decline yesterday. 28 million and a net loss of $0. View CURLF revenue estimates and earnings estimates, as well as analyst recommendations. April 12, 2019. 50 target, and Cresco Labs Inc. Based on a closing price Tuesday of C$13. (GTBIF) at outperform with a stock price target of $18. Curaleaf Holdings is the focus. "Cowen Inc. Acreage Holdings ( ACRGF ) was initiated market perform with a $9 price target, indicating 8. US cannabis retailer Curaleaf Holdings (Curaleaf Holdings Stock Quote, Chart CSE:CURA) gets a "Buy" rating at its going public debut from GMP Securities analyst Robert Fagan, who says the. Saturday, October 19, 2019. The average analyst consensus on Curaleaf seems to be coming in at around $16. Curaleaf Arizona provides Arizona patients pharmaceutical-grade, standardized-dose medical cannabis to improve health and well-being. It is calculated by determining the average standard deviation from the average price of the stock over one month or 21 business days. L) also gained 9%. com - Real-time Headlines - powered by FeedBurner MarketWatch. The marijuana sector has been a poor performing sector this year so I wouldn't press too hard on it, but there are still a few catalysts left this year that could help the US MSO's take a run. Curaleaf insiders loading up on the stock. -listed shares rose 9%, while the Canadian (CURA. Can Curaleaf Stock Keep Going After This Week’s 22% Pop? This Analyst Says Yes While this has certainly been an action-packed week in the marijuana industry, perhaps the biggest news is that Curaleaf Holdings ( CURLF ) has acquired a privately held U. Cannabis stocks a sea of red as Green Organic’s financing woes weigh MarketWatch. Aurora's outsized exposure to medical cannabis relative to peers is another challenge to growth as most medical markets are showing flat to declining. Friday, October 18, 2019. The deal is valued at $30. 50 fair value estimate for CURLF stock. 00 target price on the stock. Azer is also understood to have cut her price target on Cronos Group Inc (NASDAQ:CRON) to C$17 from C$21. The North American Marijuana Index, which tracks the. The analyst reiterated his buy rating on the stock and C$24 price target that is almost three times its current trading level. 4 Canadian dollars on July 26. L) also gained 9%. Curaleaf management's bullish outlook and positive EBITDA during the quarter likely led to the rise in the stock price. Tag archive for Curaleaf. Curaleaf insiders loading up on the stock. Curaleaf Raises $520M, Goes Public on CSE, & Loses 36%. At 12:46 PM ET, its stock was up 4. Find the latest CURALEAF HOLDINGS INC (CURLF) stock quote, history, news and other vital information to help you with your stock trading and investing. In a recently released analyst research report, Beacon Securities Managing Director of Equity Research, Russell Stanley, reiterated his buy rating on shares of multi-state U. "We believe that the. Today, Curaleaf Holdings Inc () (OTCMKTS:CURLF) had one of those defining sessions that may catapult CURA into investors consciences—permanently. 00, suggesting that the stock has a possible upside of 46. The dispensary opened its doors on Panama City Beach's prominent coastline on October 30. (CURLF) at outperform with a $10. 5 million, of which $10 million is to be paid in cash, $20. (CSE:CURA) (OTC:CURLF) with a price target that suggests some noteworthy upside to come. Using equity center you examine different market driven as well as company specific characteristics using powerful technical, fundamental, predictive and other CURALEAF HOLDINGS INC specific modules. $16 TARGET IN THE SHORT TERM. 8 million became public. The brokerage issued a sell rating and a $5. Securities products and services offered to self-directed investors through ST Invest, LLC. The company’s consensus target price was 18. 30, that puts the total purchase price at C$1. com - Real-time Headlines - powered by FeedBurner MarketWatch. On the first day of 2018, widely followed analyst Gene Munster of the venture capital firm Loup Ventures predicted Amazon would buy Target this year, a forecast that has yet to pan out with 22. -listed shares CURLF, +8. The company embarking on an aggressive acquisition drive has continued to excite investors, a development that has seen the share price nearly double in value. Target stock price target is $107. The high price target for CURLF is $11. Curaleaf Holdings is the focus. presence puts the company at a disadvantage in international markets, but that dynamic would shift should the U. Get the latest. Curaleaf Holdings Inc (OTCMKTS: CURLF) stock price continues to grow sharply as investors react to a string of strategic investments that position the company for robust growth. 93 with a high estimate of C$24. 2 comments on " Marijuana firm Curaleaf makes stock trading debut in Canada with $4B valuation " Lucas on October 29th, 2018 - 3:36pm The underwriters did an irresponsible job in pricing this deal as it closed down over 35% where they priced it at $8. Curaleaf started at outperform with $10. For Aurora, the issue is profitability, which Kirk expects will generally get worse before it gets better. $16 TARGET IN THE SHORT TERM. Saturday, October 19, 2019. multi-state operators (MSO) today. com, Kirk is ranked #4736 out of 5549 analysts. Analyst Christopher Carey of BAML has downgraded shares of Aurora Cannabis from "buy" to "neutral" and has lowered his price target on the stock from $10 to $8. 33, close to its 52-week low of $2. Northland Securities analyst Paul Penney maintained a Buy rating on MedMen Enterprises Inc (MMNFF) today and set a price target of $9. 000 CAD Lowest Target Stock quotes by finanzen. Our target price. multi-state cannabis producer called Grassroots for $875 million. Tag archive for Curaleaf. 10 Biggest Price Target Changes For Wednesday. MKM Partners analyst William Kirk initiated coverage with a Sell rating on Curaleaf Holdings Inc (CURLF - Research Report) on September 19 and set a price target of $5. (CRLBF) at outperform with a $14 target. 03 Canadian dollars. The North American Marijuana Index, which tracks the. Find market predictions, CURA financials and market news. Cowen placed a $10. On Wednesday, Alibaba stock closed at 142. The firm also posted widening net losses at US$24. The analyst reiterated his buy rating on the stock and C$24 price target that is almost three times its current trading level. Curaleaf remains a best-in-class operator in the fragmented U. The chart is intuitive yet powerful, offering users multiple chart types including candlesticks, area, lines. Curaleaf's CEO, Joseph Lusardi, said, "Our industry needs, wants and appreciates the work the FDA is doing to ensure there is regulation and compliance in the CBD marketplace. TheStreet Ratings updates stock ratings. So keep your eyes on Curaleaf Holdings. Curaleaf's report included data that showed retail and wholesale revenue grew at a rate of 500%, totalling $16. While this stock might not have as high a target price as Curaleaf, it certainly has the triple-digit growth in share price. 3, 2019 /CNW/ -- Curaleaf Holdings, Inc. 7% for the S&P 500. US cannabis retailer Curaleaf Holdings (Curaleaf Holdings Stock Quote, Chart CSE:CURA) gets a "Buy" rating at its going public debut from GMP Securities analyst Robert Fagan, who says the. 99 and a low estimate of C$5. 2 per cent below MedMen's current share price. This press release is not an offer of securities for sale in the United States, and the securities described in this press release may not be offered or sold in the United States absent registration or an exemption from. These facilities target the more upscale and sophisticated customer who has no ties to stoner culture. Kirk rates Curaleaf's Canada-listed stock a sell and has a stock price target of C$5 ($3. Their average twelve-month price target is $8. Our Curaleaf Holdings Inc (CURA) consensus estimates gives you the next 12-Months price consensus forecasts, based on industry's top analysts. The current operation rate is due to a one-time, $25 million charge that occurred as Curaleaf completed an acquisition during the year. Bank of America Merrill Lynch gives the note “NEUTRAL” instead of the previous “BUY”. Despite the lower-than-expected revenues and EPS, the stock rose 9. However, with the stock already up 135% in the past year, Carter says Cronos is fully valued at today's prices. Never miss a news story in the cannabis world. 00, which implies nearly 50% upside from current levels. Shares of Curaleaf Holdings Inc (CURA - Research Report) were revisited by a Wall Street analyst yesterday. April 12, 2019. Target stock price history Target stock historical price chart. The price tag? A cool $950 million. TSE:CURA's price target is C$16. (To watch Hundley's track record, click here ) Hundley commented, "We view any weakness in CURLF shares as near-term buying opportunities for investors. According to the company's press release, Curaleaf will provide medical cannabis patients. (CSE: CURA /OTCQX: CURLF), a leading vertically integrated cannabis operator in the United States , today announced that on Friday, September 27, 2019 Executive Chairman Boris Jordan purchased 100,000 shares of Curaleaf stock on the open market at an average price of $8. multi-state cannabis producer called Grassroots for $875 million. With respect to the terms of each of the Original Merger Agreement and the Amended Merger Agreement, Curaleaf has relied upon the exemptions provided under Sections 5. The volatility of a stock over a given time period. The stock, which began trading Oct. Azer started Green Thumb Industries Inc. Aurora shares were on the decline after BofA Merrill Lynch downgraded the stock to neutral from buy and lowered its price target to $8 from $10 Cannabis stocks were flat as a pancake on Thursday across North American markets. View CURLF revenue estimates and earnings estimates, as well as analyst recommendations. A lot of this comes down to two moves by Aleafria. (OTC: CURLF) has seen its stock rally in 2019, despite a general decline in the pot-stock market. They have all of their product on display and the prices are clearly posted on the TVs. In addition to Canopy, Inton says Curaleaf is a top cannabis stock pick based on its current valuation. 38% at outperform with a stock price target of $18. (CSE: CURA /OTCQX: CURLF), a leading vertically integrated cannabis operator in the United States , today announced that on Friday, September 27, 2019 Executive Chairman Boris Jordan purchased 100,000 shares of Curaleaf stock on the open market at an average price of $8. cannabis retailer Curaleaf Holdings Inc is raising about $400 million, almost three times its original target, in Toronto, in a deal that would value the company at close to $4 billion. 91 a share for Curaleaf, the $949 million of stock the company will issue in the deal would add to its own $4. A lot of this comes down to two moves by Aleafria. (CSE:LEAD) via a reverse takeover by PalliaTech, Inc. CURLF The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of EGBN, MNK and CURLF. Curaleaf’s stock peaked at about $15 in May but had been trending downward, losing more than 45 per cent of its value in two months. Latest stock price today and the US's most active stock market forums. Share price weakness plus a number of upcoming catalysts make cannabis company Curaleaf Holdings (Curaleaf Holdings Stock Quote, Chart: CSE:CURA) a buy, says analyst Robert Fagan of GMP Securities. The fundraising is nearly three times the initial target of $150 million and the offer is expected to be priced as early as Wednesday. 03 Canadian dollars. This is 190% above Curaleaf’s current price of $8. Curaleaf is listed as a “strong buy” with an average price target of C$19. The cannabis operator has 15 days to submit a written plan to address the violations. 3% on the stock market today. Find the latest CURALEAF HOLDINGS INC (CURLF) stock quote, history, news and other vital information to help you with your stock trading and investing. On the first day of 2018, widely followed analyst Gene Munster of the venture capital firm Loup Ventures predicted Amazon would buy Target this year, a forecast that has yet to pan out with 22. The marijuana sector has been a poor performing sector this year so I wouldn't press too hard on it, but there are still a few catalysts left this year that could help the US MSO's take a run. (GTBIF) at outperform with a stock price target of $18. ( See Curaleaf's price targets and analyst ratings on TipRanks ) The post Curaleaf Holdings: FDA Warning Letter Creates Buying Opportunity, Says Analyst appeared first on TipRanks Financial Blog. Reminds Investors That Class Action Lawsuits Have Been Filed Against Curaleaf, 2U, Granite Construction, and Pluralsight and Encourages Investors to Contact the Firm. MSOs Three of the Leading Multi-State Operators Received Outperform Ratings and Bullish Price Targets One of Wall Street's most respected cannabis analysts initiated coverage on five U. 91 a share for Curaleaf, the $949 million of stock the company will issue in the deal would add to its own $4. Curaleaf has agreed to acquire Acres Cannabis for $70 million plus earnouts. multi-state operators (MSO) today. of Brokers 8 Median Target 19. Bank of America Merrill Lynch gives the note "NEUTRAL" instead of the previous "BUY". shares of Curaleaf hold an average price target of C$16. The Company is focused on research and development capabilities to distribute cannabis products. The opening in Titusville extends Curaleaf’s position as a leading provider of medical marijuana in Florida. Those prospects, together with the anticipated legalization of cannabis in New York and New Jersey, led him to slap a price target of $20 Canadian dollars on the shares, an increase of 133% on. (CSE:LEAD) via a reverse takeover by PalliaTech, Inc. Following the release of the Warning Letter, Curaleaf saw its stock price take a hit, closing down 3. CURLF's price target is $12. 17%, bringing the stock price to $9. INVESTOR ALERT - SAExploration Holdings, Inc. The brokerage issued a sell rating and a $5. However, with the stock already up 135% in the past year, Carter says Cronos is fully valued at today's prices. operator Curaleaf Holdings Inc. (CRLBF) at outperform with a $14 target. 8) price target, or half its current price of $10. 30, that puts the total purchase price at C$1. Our Curaleaf Holdings Inc (CURA) consensus estimates gives you the next 12-Months price consensus forecasts, based on industry's top analysts. 50 price target on Curaleaf, which represents potential upside of 41% from its close on Thursday, Sept. These are breaking news. Investing in securities products involves risk, including possible loss of principal. Find the latest CURALEAF HOLDINGS INC (CURLF) stock quote, history, news and other vital information to help you with your stock trading and investing. For Aurora, the issue is profitability, which Kirk expects will generally get worse before it gets better. Curaleaf Hldgs Inc. 06% at outperform with a $10. Find the latest CURALEAF HOLDINGS INC (CURLF) stock quote, history, news and other vital information to help you with your stock trading and investing. Acres has developed a range of cannabis operations in the state of Nevada. Analyst Robert Fagan slapped a $20 Canadian dollars target price on the shares of this company, implying 133% upside. 09:50 AM ET. The deal expands Curaleaf’s footprint to 19 states from 12, including Illinois, which recently became the 11th state to legalize recreational marijuana Cannabis stocks perked up on Wednesday, with broad-based gains across North American markets. While this stock might not have as high a target price as Curaleaf, it certainly has the triple-digit growth in share price. multi-state operators (MSO) today. The target represents 24% downside from the stock's Thursday closing price of $1. Curaleaf Holdings, Inc. 11:53 AM ET. Cannabis Stock News. 299 CAD Highest Target 25. Wall Street's Top Cannabis Analyst Issues Price Targets and Initiates Coverage on 5 U. Curaleaf acquires Acres Cannabis on 2019-03-20 for $70000000. 00, suggesting that the stock has a possible upside of 46. Wall Street Stock Market & Finance report, prediction for the future: You'll find the CURALEAF HLDGS INC (LDVTF) share forecasts, stock quote and buy / sell signals below.